Horizon 2020
Generated by GPT-5-miniExpansion Funnel Raw 175 → Dedup 25 → NER 19 → Enqueued 14
| Horizon 2020 | |
|---|---|
| Name | Horizon 2020 |
| Type | Research and innovation funding programme |
| Region | European Union |
| Period | 2014–2020 |
| Budget | €77 billion |
| Successor | Horizon Europe |
Horizon 2020
Horizon 2020 was the European Union research and innovation framework programme for 2014–2020 designed to boost scientific excellence, industrial competitiveness, and societal challenges across European Commission, European Parliament, Council of the European Union and national funding agencies such as National Research Foundation (South Africa), Science Foundation Ireland, Deutsche Forschungsgemeinschaft, Agence Nationale de la Recherche, and Horizon Europe stakeholders. It aimed to align priorities from institutions like European Research Council, European Institute of Innovation and Technology, European Investment Bank, European Central Bank, and regional bodies such as Committee of the Regions and Covenant of Mayors to translate projects into impacts for actors including Siemens, IBM, AstraZeneca, Novartis, and universities like University of Oxford, University of Cambridge, École Polytechnique, Technical University of Munich, KU Leuven, and Università di Bologna.
Background and Objectives
Horizon 2020 originated from policy debates involving Lisbon Strategy, Europe 2020 strategy, Copenhagen criteria, Bologna Process, Barcelona European Council, Treaty of Lisbon, and actors such as José Manuel Barroso, Jean-Claude Juncker, Ursula von der Leyen, Herman Van Rompuy, Manfred Weber, Guy Verhofstadt, and Martin Schulz to respond to crises referenced by 2008 financial crisis, European sovereign debt crisis, Great Recession, and technology shifts driven by Apple Inc., Google LLC, Microsoft Corporation, Tesla, Inc., and Facebook. The objectives emphasized strengthening the European Research Area, fostering innovation ecosystems linked to EUREKA, CERN, EMBO, ESA, ESO, EMBL, European Molecular Biology Laboratory, and supporting breakthroughs comparable to achievements by Marie Curie, Alexander Fleming, Ada Lovelace, Alan Turing, and Rosalind Franklin.
Structure and Funding Instruments
The programme combined mechanisms from Framework Programme (FP) traditions, merging tools used by Seventh Framework Programme, FP6, FP7, and aligning with financial instruments from European Structural and Investment Funds, Connecting Europe Facility, European Investment Fund, and Juncker Plan (Investment Plan for Europe). Instruments included grants, prizes, public–private partnerships with Innovative Medicines Initiative, Clean Sky, Fuel Cells and Hydrogen Joint Undertaking, Bio-based Industries Joint Undertaking, and procurement actions modelled on Pre-commercial procurement and Public procurement of innovative solutions. Funding lines were administered through units linked to Horizon 2020 administrative bodies, research councils such as UK Research and Innovation, Swiss National Science Foundation, Norwegian Research Council, and financial intermediaries like European Bank for Reconstruction and Development.
Participation and Eligibility
Participation rules drew on models used by Erasmus+, Marie Skłodowska-Curie Actions, COST (European Cooperation in Science and Technology), and bilateral schemes involving National Science Foundation (United States), Japan Society for the Promotion of Science, Canadian Institutes of Health Research, Australian Research Council, and China Scholarship Council. Eligible entities included higher education institutions like Sorbonne University, research organisations such as Max Planck Society, small and medium enterprises including Spotify, ARM Holdings, large industry partners such as Airbus, Rolls-Royce Holdings, and public bodies from Italy, Spain, Poland, Greece, Portugal, Romania, Hungary, Bulgaria, Sweden, Denmark, Finland, Norway, Iceland, Turkey, and Israel through associated country agreements.
Key Programmes and Pillars
The programme was organized into three pillars influenced by frameworks from OECD, UNESCO, World Bank, and European Council on Foreign Relations policy thinking: Excellent Science (notably through European Research Council and Marie Skłodowska-Curie Actions), Industrial Leadership (engaging Small and Medium-sized Enterprises, European Institute of Innovation and Technology, KICs, and corporations like Philips and Bosch), and Societal Challenges (targeting areas linked to Horizon Europe priorities such as health, energy, transport, climate action, and digitalisation, with collaborations referencing World Health Organization, UNFCCC, International Energy Agency, European Space Agency, and European Environment Agency). Major calls drew participation from consortia including Graphene Flagship-linked teams, Human Brain Project collaborators, and projects involving institutions such as Imperial College London, ETH Zurich, CNRS, CNR (Italy), Spanish National Research Council, and Academy of Sciences of the Czech Republic.
Implementation and Administration
Administration was coordinated by the European Commission Directorate-Generals in partnership with agencies such as the Research Executive Agency, Innovation and Networks Executive Agency, European Research Council Executive Agency, and national contact points modelled on Marie Curie Actions support units. Project evaluation used peer review panels drawing reviewers from Royal Society, Academia Europaea, National Academy of Sciences (US), German National Academy of Sciences Leopoldina, Academy of Sciences of Ukraine, Polish Academy of Sciences, and auditing was overseen by institutions like the European Court of Auditors and budget scrutiny by European Court of Justice-related mechanisms.
Impact and Results
Outcomes included publications in journals such as Nature, Science, The Lancet, Cell, and Proceedings of the National Academy of Sciences, patents registered with European Patent Office, spin-offs akin to DeepMind Technologies origins, and collaborations feeding into initiatives led by World Economic Forum, European Investment Bank, JRC (Joint Research Centre), and policy briefs used by European Central Bank committees. Metrics referenced by analysts at RAND Corporation, Bruegel, Centre for European Policy Studies, and Brookings Institution documented enhanced cross-border collaboration among universities like Uppsala University, University of Amsterdam, Helsinki University', research institutes such as Fraunhofer Society, Istituto italiano di tecnologia, and companies including Renault, Volvo Group, Schneider Electric.
Criticisms and Controversies
Critiques were raised by commentators connected to Transparency International, Corporate Europe Observatory, Friends of the Earth Europe, European Digital Rights (EDRi), Amnesty International, and policy critics from Austrian Academy of Sciences and Royal Society about administrative complexity, distributional biases favoring institutions like Cambridge, Oxford, ETH Zurich, CNRS, and industrial partners such as Siemens and Philips, and geopolitical disputes involving United Kingdom withdrawal processes related to Brexit, European Union–Turkey relations, Switzerland–EU bilateral agreements, and associated country negotiations with Israel and Norway. Additional controversies involved ethical reviews influenced by Bioethics Advisory Bodies, data protection concerns linking General Data Protection Regulation deliberations, and debates over intellectual property arrangements involving European Patent Office and national patent offices.